Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Soft Tissue Tumor and/or Sarcoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00003316
What this trial is testing

Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the Uterus

Who this might be right for
Sarcoma
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00171912
What this trial is testing

Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes

Who this might be right for
Hypereosinophilic SyndromeSystemic MastocytosisChronic Myelomonocytic Leukemia+1 more
Novartis Pharmaceuticals 38
Testing effectiveness (Phase 2)Study completedNCT00243191
What this trial is testing

Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans

Who this might be right for
Dermatofibrosarcoma Protuberans
Sarcoma Alliance for Research through Collaboration 18
Testing effectiveness (Phase 2)Looking for participantsNCT06298916
What this trial is testing

64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer

Who this might be right for
Metastatic SarcomaEsophageal CancerGastric Cancer+3 more
Lantheus Medical Imaging 26
Large-scale testing (Phase 3)Looking for participantsNCT03016819
What this trial is testing

Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)

Who this might be right for
Alveolar Soft Part SarcomaLeiomyosarcomaSynovial Sarcoma+1 more
Advenchen Laboratories, LLC 325
Not applicableLooking for participantsNCT03889899
What this trial is testing

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.

Who this might be right for
Skin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm
Alpha Tau Medical LTD. 30
Testing effectiveness (Phase 2)Ended earlyNCT00642941
What this trial is testing

R1507 in Participants With Recurrent or Refractory Sarcoma

Who this might be right for
Sarcoma
Hoffmann-La Roche 317
Early research (Phase 1)Looking for participantsNCT05400603
What this trial is testing

Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma

Who this might be right for
NeuroblastomaRefractory NeuroblastomaRelapsed Neuroblastoma+2 more
Emory University 24
Not applicableWithdrawnNCT01492569
What this trial is testing

Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and Vomiting

Who this might be right for
Childhood Acute Lymphoblastic LeukemiaChildhood Acute Myeloid Leukemia/Other Myeloid MalignanciesEwing Sarcoma+2 more
Stanford University
Testing effectiveness (Phase 2)Study completedNCT00062205
What this trial is testing

Imatinib Mesylate in Treating Patients With Recurrent Ewing's Family of Tumors or Desmoplastic Small Round-Cell Tumor

Who this might be right for
Sarcoma
City of Hope Medical Center 40
Early research (Phase 1)Study completedNCT01453283
What this trial is testing

Tabectedin to Treat Children and Adolescents With Cancer

Who this might be right for
Solid Tumors
National Cancer Institute (NCI) 12
Early research (Phase 1)Study completedNCT00931931
What this trial is testing

HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors

Who this might be right for
RhabdomyosarcomaOsteosarcomaEwing Sarcoma+6 more
Timothy Cripe 18
Testing effectiveness (Phase 2)Ended earlyNCT03013127
What this trial is testing

Pembrolizumab in Patients With Relapsed Or Metastatic Osteosarcoma Not Eligible for Curative Surgery

Who this might be right for
Osteosarcoma
Oslo University Hospital 12
Testing effectiveness (Phase 2)Looking for participantsNCT07359053
What this trial is testing

MAGNATE-S: Paclitaxel Polymer Micelles Combo in Advanced Sarcoma

Who this might be right for
Sarcoma
Shanghai 6th People's Hospital 46
Large-scale testing (Phase 3)Study completedNCT01440088
What this trial is testing

A Trial of TH-302 in Combination With Doxorubicin Versus Doxorubicin Alone to Treat Patients With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Threshold Pharmaceuticals 640
Testing effectiveness (Phase 2)Study completedNCT00515931
What this trial is testing

Radiation Therapy as Palliative Treatment of GIST

Who this might be right for
Sarcoma
Heikki Joensuu 25
Testing effectiveness (Phase 2)UnknownNCT05193188
What this trial is testing

Anlotinib Combined With or Without PD-1 Antibody on Unresectable High-grade Chondrosarcoma

Who this might be right for
Chondrosarcoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT03967223
What this trial is testing

Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors

Who this might be right for
Neoplasms
USWM CT, LLC 103
Testing effectiveness (Phase 2)Active Not RecruitingNCT02790515
What this trial is testing

Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)Acute Myeloid Leukemia (AML)Myeloid Sarcoma+4 more
St. Jude Children's Research Hospital 170
Testing effectiveness (Phase 2)Active Not RecruitingNCT04284774
What this trial is testing

Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial

Who this might be right for
Malignant Solid NeoplasmRecurrent Adrenal Gland PheochromocytomaRecurrent Ectomesenchymoma+38 more
National Cancer Institute (NCI) 5
Next Page